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NK cells, which appear morphologically as a homogeneous population of large 
granular  lymphocytes  (LGL), ~ have  been  implicated  in  a  number  of diverse 
immunologic  functions  including  cytotoxicity against  tumor  cells  and  virally 
transformed ceils, regulation of immunoglobulin production, and regulation of 
hematopoiesis (1-4). However, despite their homogeneous morphology, NK cells 
comprise a small heterogeneous population of peripheral blood lymphocytes (5, 
6). In part, the heterogeneity of NK cells has become apparent through charac- 
terization of the cell surface antigens expressed on these cells using various mAbs 
(7-9). These studies have shown that almost all NK cells express NK-associated 
antigens such as NKH1 and B73.1, but that other antigens, such as HNK-1 and 
NKH2, are only expressed to varying degrees on subsets of LGL (10,  11). The 
vast majority of NK cells express the T1 1/E rosette receptor antigen,  but T8, 
another T  cell associated antigen,  is only expressed on -30%  of NK cells (12). 
Although  numerous studies  have indicated  that  mature  T  cells are  capable of 
NK-like activity, very few peripheral blood NK cells have been found to express 
T3 antigen, T  cell receptor (Ti) like structures, or mature T  cell antigens such 
as T1 and T12 (7). 
In recent studies, we have developed a  series of cloned human NK cell lines. 
Phenotypic analysis of these cells has revealed that, like uncultured NK cells, the 
majority of NK clones express the T11  E  rosette antigen and the pan-NK celt 
antigen NKH 1, but do not express T3 antigen or functional T  cell receptor-like 
structures (8,  13). However, unlike the majority of NK cells in peripheral blood, 
a  number  of  NK  clones  were  found  to  express  a  mature  T  cell  phenotype 
including T3 and T8 antigens  in addition to T1 1 and  NKH1.  Further charac- 
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terization of these clones showed  that  three T  cell-like NK clones, JT9, JT10, 
andJT11,  derived from the same individual expressed the same clonotypic Ti- 
like structure,  termed NKTa (14,  15).  The subsequent  identification of a  140- 
kD cell surface activation antigen termed TNK-rAR as the target antigen for NK 
clones expressing the NKTa cionotype, confirmed the MHC-independent cyto- 
lytic specificity of these cells but did not establish the functional relevance of this 
population  as  a  mediator  of NK  activity  in  vivo (16).  In  order  to  determine 
whether the T3+NKTa  + lymphocyte population is an  NK active subset present 
in unstimulated peripheral blood, we examined fresh PBMC from the donor of 
clones JT9, JT10,  and JT11  for  the  presence  of cells  expressing  the  NKTa 
clonotype. After finding a small but distinct population of cells reactive with anti- 
NKTa, we used flow cytometric cell sorting and in vitro cloning procedures to 
establish additional clones that maintain NK-like activity and express the NKTa 
clonotype. This report describes the detailed, phenotypic, functional, and genetic 
analysis of this new series of NK clones. 
Materials and Methods 
Monoclonal  Antibodies.  mAbs used in these studies have been previously described in 
detail. T3 and TI2 are pan-T cell antigens expressed on all  mature T  lymphocytes in 
human peripheral blood (17).  T4 is expressed on a subset of peripheral T  cells having 
primarily inducer/helper function. T8 antigen is expressed on a subset of peripheral T 
cells having primarily cytotoxic/suppressor function. Anti-Tl 1 defines an antigen associ- 
ated with the sheep erythrocyte receptor (18). Mol antigen has been shown to be the cell 
surface receptor for C3bi (19). NKH 1 has been defined as a pan-NK cell antigen, whereas 
NKH2 has been shown to identify a  subset of LGL with relatively low NK activity in 
unstimulated peripheral blood (11). B73.1 defines the FcR2 receptor present on NK cells 
and granulocytes (kindly provided by Dr. B. Perussia, Wistar Institute, Philadelphia, PA) 
(10).  HNK1 antigen is expressed on ~60% of NK cells in normal peripheral blood and 
on some T  lymphocytes that do not have NK activity (11, 20). Anti-transferrin receptor 
antibody (5E9) was obtained from American Type Culture Collection, Rockville, MD. 
The mAbs anti-NKTa and anti-NKTb have been shown to be specific for a T3-associated 
clonotypic T  cell receptor-like structure on cloned human  NK cell lines (14,  15).  The 
mAbs  anti-TNKvAa  (16)  and  4F2  (21)  define  a  140-kD  early activation  antigen  on 
hematopoietic cells. 
Phenotypic Analysis of Cell Surface Antigens.  Human peripheral blood mononuclear cells 
(PBMC) were isolated from healthy volunteer donors by Ficoll-Hypaque (F/H) density 
gradient centrifugation. 
Phenotypic analysis  of normal PBMC and cloned cell lines was performed by indirect 
immunofluorescence with fluorescein-conjugated goat anti-mouse Fab IgG as described 
previously (11).  Samples were analyzed on an  Epics V  or an  Epics C  flow cytometer 
(Coulter Electronics Inc., Hialeah, FL).  10,000 cells were analyzed in each sample and 
the results presented as histograms which display the number of cells (ordinate) versus 
the intensity of fluorescence (abscissa) expressed on a logarithmic scale for each reagent. 
The negative control used to determine background fluorescence was an ascites derived 
from a  nonreactive hybridoma,  mAbs  were  always  used  at  saturating  concentrations 
(1:100-1:500).  In  experiments that evaluated the presence of NKTa  ÷ cells  in  normal 
PBMC, 100,000 cells were analyzed with anti-NKTa and with negative ascites. 
Purification  ofNKTa ÷ Cells.  Before flow cytometric sorting of NKTa  ÷ cells, an immune 
rosetting technique was used to enrich for this population of cells.  Nonadherent PBMC 
were incubated at a concentration of 25 ×  106 cells/ml for 30 min at 4 °C with saturating 
amounts of anti-NKTa.  Unbound antibody was removed by two wash  steps and mAb- 
treated cells were mixed with a  10% (vol/vol) solution of anti-Ig coated ox erythrocyte 
suspension at a ratio of 0.75 ml for 108 PBL to form immune rosettes. The mixture was 814  CLONOTYPIC ANTIGENS ON  NATURAL KILLER CELLS 
pelleted (300 g, 10 min) and incubated for 20 min at 4°C. The ox red cell PBMC mixture 
was resuspended vigorously and rosetted cells were separated from nonrosetting cells by 
F/H density gradient sedimentation.  Rosetted NKTa  + cells were recovered from the F/ 
H  pellet  by  hypotonic  lysis.  Subsequently,  cells  were  washed  twice  and  the  immune 
rosetting procedure was repeated with the NKTa-enriched fraction. The entire procedure 
was performed in RPMI  1640 containing 5% pooled human AB serum at 4°C. Viability 
was consistently >95% in all cell fractions. After an overnight incubation at 4°C, rosette 
positive  cells  were  separated  into  NKTa  +  and  NKTa-  fractions  using  a  cell  sorting 
procedure.  Briefly, rosette positive cells were incubated  with anti-NKTa for 30 min at 
4°C, washed twice, and then incubated with GM-FITC for an additional 30 min at 4°C. 
After two additional washes, NKTa  + fluorescent cells were separated from nonfluorescent 
cells using an Epics V (Coulter Electronics Inc.). Background fluorescence was determined 
with a nonreactive hybridoma ascites, and positive cells were sorted in 10% pooled human 
AB serum at a rate of 3,000 cells/s. Cell sorter purified NKTa  + cells were either cloned 
directly into 96 well plates at 1 cell/well using the Epics V autocloning procedure, or by 
limiting dilution technique plating 1 cell/well. In either case, cells were cloned into sterile 
V bottom microtiter plates. 
Generation of Human Cloned Cell Lines.  Methods for generation of human NK cloned 
cell lines have been described in detail (22). Briefly, NKTa  + cells obtained by immunoflu- 
orescent sorting were cloned at 1 ceil/well on a feeder layer of allogeneic irradiated (5,000 
rad) PBMC plus allogeneic irradiated (5,000 rad) EBV transformed B cells.  All colonies 
were  expanded  by addition  of fresh culture  medium  every  3  d.  Culture  medium  was 
RPMI  1640 supplemented  with  1% penicillin-streptomycin,  1% sodium pyruvate,  20% 
human  AB  serum,  and  10%  lymphocyte conditioned  medium  (LCM).  Preparation  of 
LCM  containing  IL-2 has  been  described  previously (11).  All  cell  lines  used  in  these 
studies  have  been  subcloned  at  least  three  times  at  100  cells/well  on feeder  layers of 
allogeneic irradiated PBMC plus EBV transformed B cells. 
Clones CNK11, CNKI2, CNK13, CNK14, and CNK15 were derived from cloning of 
purified  NKTa  + cells  from  normal  peripheral  blood.  Clones  CNK8  and  CNK9  were 
derived from the same individual in experiments performed 6  mo before the sorting of 
NKTa  + cells.  These two clones were generated following the cell sorter purification and 
cloning of NKH2 + cells from PBMC (11,  13). NK clones JT9, JT 10, and JT 11 have been 
described in detail (14-16).  Each of these clones was derived at different times from the 
same individual and have previously been shown to express the NKTa clonotype. CNK3 
is a T3 +, TI 1  +, NKH1 +, NKH2  ÷, NKTa- NK clone from a different donor (23). JT3 is a 
T3-, Tll +, NKH1 +, NKH2  +, and JTB18  is a  T3-, Tll +, NKH1 +, NKH2- NK clone. 
Both  clones  have  been  described  in  detail  previously (8,  11).  CNK6  is  a  T3-,  T11 +, 
NKH 1  +, NKH2  + clone, which was also generated from NKH2  + sorted cells. 
Cytotoxicity Assays.  Cytotoxicity assays were performed according to a standard chro- 
mium release method previously described (23). All experiments were done in triplicate 
using V  bottom microtiter plates.  Medium was RPMI  1640 plus 5% pooled human AB 
serum and 1% penicillin-streptomycin. Assays were performed at various E/T ratios using 
5,000 target cells/well. REX and Molt-4 are T  cell leukemia cell lines, whereas K562 is a 
myeloid cell line established from a patient with chronic myelogenous leukemia. Daudi is 
a  Burkitt lymphoma cell line.  U937  cells were derived from a  monocytic leukemia and 
HL-60 cells from a  promyelocytic leukemia.  Laz 461  is an EB virus transformed B cell 
line derived from the same donor as the NKTa  + NK clones. 
Inhibition studies were performed at an E/T ratio of 5:1 and by preincubating either 
the effector cells with anti-NKTa, anti-NKTb, anti-T3, or anti-NKH1  mAb for 30 min 
at 37°C, or by preincubation of the target cells with anti-TNKTAR, 4F2, both mAbs, or 
5E9 antibody for 30 min at room temperature. 
Southern Blot Analysis.  DNA from the NK clones and an EBV transformed B cell line 
(Laz 461) was extracted using standard methods (24, 25). DNA was digested with either 
Eco  RI  or  Barn  HI,  fractionated  on  0.8%  agarose  gels,  transferred  to  nitrocellulose 
membrane,  and  hybridized  with  raP-labeled  Ti  C3  probe.  The  probe  specific  for  the 
constant region gene of Ti 3 REX (C/3 REX) used in southern blot analysis was purified SCHMIDT  ET  AL.  815 
FIGURE  1.  Identification  of peripheral  blood lymphocytes reactive with anti-NKTa mAb. 
Nonadherent PBMC were enriched  for NKTa  ÷ cells by immune rosetting with anti-NKTa- 
coated  ox  RBC. Enriched  cells were  subsequently  incubated  with additional  anti-NKTa 
antibody, stained with goat anti-mouse lg FITC and 100,000 cells analyzed using an Epics V 
flow cytometer.  (A)  In  this  three-dimensional  analysis, the X-axis represents  fluorescence 
intensity on a log scale, the vertical Y-axis represents  cell number, and the Z-axis represents 
cell size. (B) The dot matrix analysis for the same population is also shown. Here the X-axis 
represents  fluorescence intensity on a log scale and the Z-axis represents cell size. Region 1 
'represents a discrete  population  with high  intensity expression of NKTa antigen,  whereas 
region  2 represents  a relatively low degree of binding  of anti-NKTa  which is likely to be 
nonspecific. 
from p/3REX  with Eco RI and Bgl II (New England  Biolabs, Beverly, MA) and labeled 
with ~2p by nick translation.  The isolation of this cDNA clone encoding Ti C/3 REX has 
been  described  in  detail  previously (26).  The  filters  were  hybridized  in  6x  standard 
phosphate saline EDTA (SSPE)  at 68 °C overnight, washed in  1  ×  SSPE plus 0.1% SDS at 
room temperature for 30 min, 0.5x SSPE plus 0.1% SDS at 68°C for 30 rain, and then 
twice in 0.2x SSPE plus 0.1% SDS at 68°C for 60 rain, and membranes were exposed to 
Kodak XR film (Eastman Kodak Co., Rochester, NY) overnight. 
Results 
Identification of NKTa + Cells in Unstimulated Peripheral Blood.  In earlier stud- 
ies it was  found  that  three  NK clones  generated at  three  different  times  from 
the same individual during a period of two years revealed an identical mature T 
cell-like phenotype (T3+T8÷T1 I+NKHI+NKTa÷), and identical  cytotoxic spec- 
ificity (14,  15).  In the present studies,  we examined the peripheral blood of the 
same individual  for the presence of cells expressing the NKTa clonotype. Using 
indirect  immunofluorescence  reactivity with  monoclonal  anti-NKTa  antibody, 
flow cytotnetric  analysis of 100,000  PBMC  indicated  the presence of only 323 
NKTa  + cells.  Since  control  cells incubated  with negative ascites and GM-FITC 
contained  130 nonspecificaily fluorescent ceils/100,000  cells analyzed, this anal- 
ysis  suggested  that  NKTa +  cells  occurred  at  a  frequency  of  0.19%  in  this 
individual.  In several repeat experiments using either anti-NKTa or anti-NKTb, 
the range of NKTa + cells was found to be between 0.2 and 0.09% (mean 0.15% 
NKTa  + cells). 
As  this  low  frequency  of positive cells  was  very difficult  to  distinguish  from 
nonspecific background  fluorescence,  we applied  two adherence  steps and  two 
positive  immune  rosetting  procedures  with  anti-NKTa  antibody  to  enrich  for 
cells  that  express  the  NKTa  clonotype.  As  shown  in  Fig.  1,  we  were  able  to 
obtain a  20-50-fold enrichment using these procedures so that in several exper- 816  CLONOTYPIC  ANTIGENS 
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FrGURE 2.  Surface  phenotype of NKTa  + cell lines. 10,000 cells were analyzed by indirect 
immunofluorescence  and each histogram  displays  the number of  cells (ordinate)  vs. the intensity 
of fluorescence  (abscissa) expressed on a logarithmic  scale. Negative  control used to determine 
background fluorescence  was an ascites derived from a nonreactive hybridoma. 
iments the  level  of reactivity was  increased  to  2.5-5%  NKTa  ÷ cells.  Indirect 
immunofluorescence analysis of the enriched cell population with anti-NKTa is 
shown  in  Fig.  1.  Fig.  1 A  and  region  1  in  Fig.  1 B  clearly  depict  a  discrete 
population of high density NKTa  + cells, which in this experiment, represented 
2.5% of 100,000 cells analyzed. The low density NKTa  + population outlined in 
region 2  of Fig.  1 B likely represents nonspecific binding of anti-NKTa. There- 
fore, we did not purify or characterize  these cells in further experiments.  An 
alternative possibility is that this low density NKTa  + population  is  due  to the 
modulatory effects of anti-NKTa during the overnight incubation period. 
Direct Cloning ofNKTa + Cells.  In order to further characterize NKTa  + cells 
in normal peripheral  blood, we used immunofluorescent cell sorting to purify 
celts outlined in region 1 shown in Fig. 1 B. NKTa-purified cells were then cloned 
into 800 wells using either autocloning or limiting dilution techniques, both at a 
plating frequency of 1 cell/well. After 3 wk of in vitro culture, 35 colonies were 
established and these were individually screened for killing of K562 target cells. 
31  of 35  colonies (89%)  were  cytotoxic for  K562  and  were  therefore  felt to 
exhibit NK activity. Five of these clones could be established in long term culture 
and were used for further phenotypic and functional studies. 
Generation  of NKTa ÷ Clones Following Purification of NKH2 ÷ Cells.  In a  sepa- 
rate series of experiments designed to generate NK clones with specific pheno- 
types,  NKH2 + cells were purified from normal  nonadherent PBMC using im- 
munofluorescent cell sorting on the Epics V. NKH2 antigen has previously been 
identified on ~50% of NK clones. However, large granular lymphocytes (LGL) 
in unstimulated peripheral blood that express NKH2 do not have a high degree 
of NK activity. When NKH2 sorted cells were purified from the same donor as 
clone JT9,  cells were cloned by limiting dilution into 800  individual wells at a 
concentration  of  1  cell/well  using conditions  identical  to  those  described  for 
generation  of other  NK  clones.  In  this  experiment,  nine  colonies  could  be 
expanded  for  further  phenotypic and  functional analysis.  Each  of these  nine 
clones expressed NKH2 antigen and, interestingly, two clones, CNK8 and CNK9, 
also expressed the NKTa clonotype. 
Phenotypic  Characterization  of NKTa* Clones.  Fig.  2  shows the results of the 
phenotypic analyses of all new NKTa  + clones. All clones were tested for expres- 
sion  of the  NKTa  clonotype  as  well  as  a  number  of other  T  cell  and  NK- SCHMIDT ET  AL. 
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Cytotoxicity of NKTa + NK Cell Lines 
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Effectors 
Targets 
K562  REX  Molt-4  U937  Daudi  Laz 461  HL60 
NKTa  ÷ clones 
JT9  83*  74  79  19  62  70  16 
CNK8  87  65  81  2  70  24  13 
CNK9  67  13  42  3  41  59  16 
CNKI 1  75  48  42  3  53  71  23 
CNK12  83  40  75  3  41  23  16 
CNK13  81  47  70  27  61  23  33 
CNK 14  68  66  60  10  27  23  17 
CNK15  82  72  79  12  39  77  18 
NKTa- clones 
JT3  73  76  78  0  41  12  23 
JTB18  81  94  86  98  78  38  59 
CNK6  81  83  88  5  27  18  30 
* Percent specific cytotoxicity, SD _< 5%. 
associated surface antigens. Moreover, the phenotype of CNK8 and CNK9, and 
the clones obtained from direct sorting of NKTa  + cells, was compared with that 
of the previously established NKTa  ÷ clone, JT9. Previous reports (14-16) have 
shown that the phenotype of clones JT10 and JT11  is identical to that of  JT9. 
As shown in Fig. 2, all clones express the clonotypic antigens NKTa and NKTb, 
and all are positive for antigens T3, T8, T11, T12, and Mol. Similarly, the pan- 
NK cell antigen, NKH1, is expressed on all clones. All clones are negative for 
T4 and HNK1  (data not shown), but there are differences in the expression of 
NKH2. NKH2 is expressed on CNK8, CNK9, CNK11, CNK12, and CNK13, 
but not onJT9,JT10,JT11, CNK14, and CNK15. Thus, 50% of NKTa  ÷ clones 
express NKH2 to a large extent, and 50% do not express antigen detectable by 
indirect immunofluorescence. 
Natural Killer Activity  of NKTa + Clones.  To evaluate the cytolytic activity of 
NKTa  + clones obtained in various ways, we tested all clones against a series of 
seven  different target  cells.  The  cytotoxic specificity of all  NKTa  ÷ clones  is 
depicted in Table I and shows approximately equivalent cytotoxicity against this 
panel of targets. K562 and Molt-4 appear to be the most sensitive target cells 
and are uniformly killed by all clones. The target cell lines U937 and HL60 are 
quite resistant to cytotoxicity of NKTa  + clones, although there is a low degree 
of killing in some instances. There is also a cytotoxic effect of all clones against 
the autoiogous EBV transformed B cell line Laz 461.  Also shown in Table I is 
the cytotoxic activity of three NKTa-,T3-,NKH 1  + NK clones against the same 
targets.  In  these experiments, the  NKTa  + clones are  shown to  have a  broad 
range of cytolytic activity that is similar to that seen for NK clones, CNK6 and 
JT3. In contrast, clone JTB18 has more activity against targets, U937 and HL- 
60, which are resistant to lysis by NKTa  + clones. 
Inhibition  of Cytotoxicity  by mAbs,  Anti-NKTa,  and Anti-NKTb.  Previous char- 
acterization  of the  NKTa  antigen  has  shown  that  this  structure  is  a  90-kD 
heterodimer that resolves into two distinct bands of 49  kD and  43  kD under 818  CLONOTYPIC  ANTIGENS  ON  NATURAL  KILLER CELLS 
TABLE lI 
Inhibition  of NK Activity of NKTa + Clones by Anti-NKTa and Anti-NKTb mAbs 
Targets 
K562  Molt-4  Daudi 
Effectors 
Anti-  Anti-  Anti-  Anti-  Anti-  Anti-  Anti-  Anti-  Anti- 
Medium  Medium  Medium 
NKHI*  NKTa  NKTb  NKHI  NKTa  NKTb  NKH1  NKTa  NKTb 
NKTa  + clones 
JT9  82  ~  79  7  33  61  58  fi  7  66  61  5  48 
CNK8  68  65  5  16  56  52  0  0  57  55  5  25 
CNK9  75  71  5  15  32  30  G  0  66  62  6  36 
CNKII  84  83  7  27  50  47  1  1  60  57  3  20 
CNKI2  53  48  13  41  68  64  0  0  31  27  0  17 
CNKI3  72  71  10  19  30  25  5  7  41  38  7  20 
CNKI4  57  54  4  16  25  23  0  0  21  20  1  11 
CNKI5  74  70  2  27  46  44  2  2  21  18  8  12 
NKTa-clones 
JT3  64  62  61  63  76  76  76  77  31  30  28  28 
JTal8  68  63  72  63  73  71  76  76  62  62  58  61 
CNK6  78  78  76  75  83  81  82  83  22  21  21  17 
* Anti-NKH l was used as a control antibody. 
* Percent specific cytotoxicity;  SD -~ 5%; E/T ratio 5:1. 
reducing conditions in  SDS-PAGE.  Anti-NKTb may identify a  distinct epitope 
on  the  same  cell  surface  structure,  and  both  NKTa  and  NKTb  antigens  co- 
modulate  with  surface  T3  antigen.  NKTa  antigen  therefore  appears  to  be 
analogous  to  T  cell  receptor-like  structures  (Ti)  found  on  conventional  T 
lymphocytes.  To  determine  whether  all  NKTa  +  clones  use  this  antigen  as  a 
surface receptor for target antigen, we assayed the ability of anti-NKTa to block 
cytotoxicity of all NKTa  + clones. As shown in Table II, cytotoxicity of all NKTa  + 
clones could be almost completely inhibited by anti-NKTa. Moreover, this high 
degree of inhibition was seen against three different target cells, K562,  Molt-4, 
and  Daudi.  Anti-NKTb  markedly  inhibited  cytotoxicity of all  NKTa  +  clones 
when  tested  against  Molt-4  targets,  but  significantly  less  inhibition  was  seen 
against  either  K562  or  Daudi.  Although  the  effect of anti-NKTb  varied  with 
different  target  cells,  there  was  relatively  little  variation  among  the  NKTa  + 
clones. No inhibition could be observed when anti-NKH 1 was added as a control 
antibody to the assay. As shown in Fig. 2, this antibody also binds to all NKTa  + 
effector cells.  As  expected, there was  no inhibitory effect against  NKTa-  NK 
clones such as JT3, JTB18, and CNK6. 
Inhibition  of  NKTa +  Clones  by  Anti-TNKTaR.  To  determine  whether  each 
NKTa  ÷ clone had similar specificity for TNKTAR antigen,  we tested the ability 
of monoclonal  anti-TNKTAR  tO  block  NK  activity  of each  NKTa  +  clone.  In 
addition,  we  tested  4F2  mAb,  which  has  recently been  shown  to react with  a 
different epitope on the same surface structure (27). Since it has previously been 
shown that these mAbs act at the target cell level, we preincubated target cells 
with either anti-TNKTAR, 4F2, or both antibodies, and then added effectors. As 
shown in Fig.  3, there is a significant inhibition of cytotoxicity with either anti- 
TNKTAR, 4F2,  or the  combination  of both antibodies  for each  NKTa  + clone. 
Both antibodies appear to have similar inhibitory activity and the combination 
of both antibodies does not in general increase the blocking of cytotoxicity. An SCHMIDT ET  AL. 
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either media, anti-TNKTAR, 4F2, or a combination of both mAbs. Specific cytotoxicity  was 
measured 4 h after addition of target cells as described in Materials and Methods. The 
cytotoxic  assay was performed  at an E/T ratio of 5:1. 
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mAb (5E9) directed against the transferrin receptor, another activation antigen 
expressed on rapidly dividing cells, had no inhibitory effect (data not shown). 
Rearrangement of T Cell Receptor/3  Gene in NKTa + Clones.  The Ti C13 probe, 
which hybridizes equally well to the germline C~I and C/32 segments of the gene 
encoding the T  cell receptor, was used to analyze NKTa  + clones for the presence 
of clonal Ti 13 gene rearrangements. Since not all restriction enzymes will provide 
detectable  rearrangements,  digestions  with  both  Eco  RI,  which  detects  C/31 
rearrangement, and Barn HI, which detects both C/31 and C/32 rearrangements 
(28),  were performed for each cellular DNA preparation. After digestion with 
each restriction endonuclease, genomic DNA was size  fractionated by agarose 
gel electrophoresis and hybridized with S2P-labeled Ti Cfl REX probe. As shown 
in Fig. 4, all five different NKTa  + clones that were tested had identical rearrange- 
ments following Barn HI digestion. The 23 kb band seen in the Barn HI digest 
(lanes A-E) and the 10.2 and 4.0 kb bands seen in the Eco RI digests (lanes F- 
J) represent the germline configuration of the Ti j3 genes. Each NKTa  + clone 
contains an identical rearranged band of -  15 kb seen only in the Barn HI digests 
and not in the Eco RI digests. Since an Eco RI restriction site exists between the 
J and C regions of the C/32 locus (28), this finding suggests that all NKTa  + clones 
have an identical rearrangement of C/32 and are likely to have a deletion of one 
of the C/31 genes, whereas the second allele remains in germline configuration. 
Control experiments in Fig.  5  show that the C/32 rearrangement of CNK9, 
CNKll,  CNK12,  CNK14,  and  CNK15  shown  in  Fig.  4  is  identical  to  that 
previously shown for JT9  (24).  In  contrast, CNK3  cells  (lane H) have a  C/31 
rearrangement, visible in the Eco RI digest. For comparison, Laz 461  (lanes A 
and D) contains both alleles in the germline configuration. The possible deletion 820  CLONOTYPIC  ANTIGENS  ON  NATURAL  KILLER  CELLS 
FIGURE 4.  Ti/3 gene rearrangements in NKTa + clones. Southern blot analysis of DNA from 
five clones was digested with either Barn HI (lanes A-E) or Eco RI (lanes F-J) and bybridized 
with 32P-labeled Ti C/3 probe.  Lanes contained approximately  10 #g of DNA from different 
clones as follows: CNK9 (lanes A and F); CNK11  (lanes B and G); CNK12  (lanes C and H); 
CNK14 (lanes D and I); CNK15 (lanes E and J). 
FIGURE ,5.  Southern blot analysis of NKTa  + clones compared with T3+NKTa -  clone and 
EBV-induced B cell line. DNA from NK clones or germline Laz 461 was digested with either 
Barn HI (lanes A-C) or Eco RI (lanes D-H) and hybridized with 3~P-labeled Ti CB REX probe. 
Lanes contained -10 #g of DNA from different clones as follows: Laz 461  (lanes A and D); 
CNK11  (lanes B and E); CNK12 (lanes C and F); JT9 (lane G); CNK3 (lane H). 
of one of the C/~I alleles in each NKTa  + clone is supported by the finding that 
the 10.2-kb band seen in the Eco RI digests is consistently less intense than the 
germline 4.0-kb fragment (Fig. 4). In Laz 461  cells that have neither rearrange- 
ment nor deletion of C/31 (Fig. 5, lane D), both fragments are of  similar intensity. 
Discussion 
Previous studies have described the characterization of three different NK 
clones, JT9, JT10, and JT11, derived from the same individual. Each of these 
clones was found to have a  mature T  cell  phenotype and expressed the same 
clonotypic T  cell receptor-like structure that was identified with two different 
mAbs, anti-NKTa and anti-NKTb. In subsequent experiments, anti-NKH2 an- SCHMIDT ET  AL.  821 
tibody, which defines a  subset of LGL in normal peripheral  blood, was used to 
establish  NK  clones that  express  this  antigen.  Analysis  of the  NKH2  + clones 
which resulted  from  these experiments  revealed that  two of these,  CNK8 and 
CNK9, also had a mature T  cell phenotype, and both clones expressed the same 
NKTa clonotypic receptor-like structure.  As expected, both CNK8 and CNK9 
clones expressed NKH2 antigen,  but this antigen was not expressed in the three 
original  NKTa ÷ clones JT9, JT10,  or JT11.  This  finding  thus suggested  that 
different NK clones (i.e.,  NKH2- and  NKH2  ÷ clones) might  use the same cell 
surface receptor for antigen (NKTa). Therefore, further studies initially focused 
on the identification of NKTa  + cells in unstimulated peripheral  blood from the 
same  individual  from  whom  NKTa  ÷ clones  had  been  generated.  Using  flow 
cytometric  analysis,  we  were  able  to  show  a  frequency  of  NKTa  +  cells  in 
peripheral blood of ~0.15%. Using two adherence steps and two positive immune 
rosetting procedures,  we were able to achieve a  20-50-fold enrichment  up to 
2.5-5%  NKTa + cells. Flow cytometric immunofluorescent cell sorting was then 
used to purify a  discrete NKTa + cell population and to generate an additional 
series of NKTa ÷ clones based primarily on the surface expression of this clono- 
typic antigen.  Of the 35 colonies established in this manner,  89% exhibited NK 
activity when screened for killing of K562 target cells. Five of these NK active 
clones were then expanded in vitro for phenotypic and functional characteriza- 
tion and for comparison with other NKTa + clones. 
The phenotypic comparison  of the five new NKTa  + clones with  CNK8 and 
CNK9,  and  the  previously  established  JT9  clone  confirmed  that  all  clones 
expressed  the  NKTa  clonotype  and  were  also  positive  for  NKTb,  a  second 
antigenic determinant on the same T  cell receptor-like structure. In addition, all 
clones express the T  cell antigens T3, T8, T11, and T12,  the myelomonocytic 
antigen Mol, and the pan-NK cell antigen NKH 1. In contrast, NKH2, an antigen 
that is normally expressed on a small subset of peripheral blood LGL, was only 
expressed on  half of the  NKTa + clones.  Interestingly,  this  included  all  clones 
selected for expression of NKH2 (CNK8 and  CNK9) and  three of five clones 
selected for expression of the NKTa clonotype, but none of the original clones 
selected on  the  basis  of functional  NK  activity (JT9, JT10, JTll).  Since  the 
expression of NKH2 antigen has been found to be quantitatively stable and cell 
cycle independent during prolonged in vitro culture of NK cells, the difference 
in  NKH2  antigen  expression  among  NKTa  +  clones  suggests  that  these  cells 
represent distinct clonai populations. 
With regard to the cytotoxic function of NKTa + cells, it is important to note 
that 89% of colonies selected solely on the basis of expression of NKTa clonotype 
displayed cytotoxic activity against K562.  Subsequently, the evaluation of cyto- 
lyric activity of all  NKTa  + clones against seven different targets demonstrated 
similar levels of cytotoxicity that were comparable to other NKTa- NK clones. 
For both  NKTa + and  NKTa- clones,  cytolytic activity does not appear  to  be 
MHC restricted since targets that lack either MHC class I or class II antigens are 
killed equally well. 
Since the NKTa antigen  has been defined as a  T  cell receptor-like structure, 
it was of interest to determine whether all NKTa  + clones used this antigen  for 
target cell recognition.  Cytotoxicity inhibition  studies of NKTa + clones showed 822  CLONOTYPIC  ANTIGENS  ON  NATURAL  KILLER  CELLS 
that the addition of monoclonal anti-N KTa antibody abrogated cytotoxic activity 
of all  NKTa  +  clones  almost  completely.  Although  anti-NKTb  did  not  block 
cytotoxicity against all targets, the differential blocking of anti-NKTb was found 
to be consistent among  all  NKTa  + clones.  In  contrast,  cytotoxicity of none  of 
the NKTa- clones could be blocked by either mAb against this clonotypic antigen. 
Further  analysis  of the  specificity  of  NKTa ÷  clones  at  the  target  cell  level 
indicated that all clones are specific for the same  140-kD activation antigen on 
the target cell, termed TNKa-AR. In these experiments,  preincubation  of target 
cells with anti-TN KTAR or 4F2 mAb, or a combination of both markedly inhibited 
cytotoxicity of NKTa  + clones,  whereas  NKTa-  NK  clones were  not  affected 
(data not shown). Taken together, these results provide strong evidence that the 
cytotoxic specificity of NKTa + clones is conferred by the NKTa structure. 
Since a  small population  of peripheral  blood lymphocytes appear  to use the 
same  NKTa structure  for target  cell recognition  despite expression of at  least 
two different phenotypes, it was important  to determine whether these pheno- 
typically distinct clones would express identical T  cell receptor gene rearrange- 
ments. Using the Ti C/3 REX probe, it was found that each NKTa  ÷ clone contains 
an  identical  rearranged  band  of  ~15.0  kb  in  the  Bam  HI  digests,  and  no 
rearrangements were present in the Eco RI digests. These data therefore indicate 
that all NKTa  + clones have an identical Ti/3 gene rearrangement  using C/32 and 
not C/31. It can therefore be presumed that a functionally rearranged C/32 gene 
(VDJC) plays a  role in determining  the  MHC independent  specificity of these 
NKTa  +  NK  clones  for  TNKTAR antigen.  Ti  o~  rearrangements  could  not  be 
evaluated in this series of NK clones, and the possibility remains that relatively 
minor differences in their specificity may be due to different rearrangements  of 
the Ti a  subunit. 
These  results  with  NKTa + clones contrast  sharply  with  recent  reports  that 
have described the expression of other clonotypic T  cell receptor-like structures 
present in low percentages (~2%) in peripheral blood of normal individuals (29- 
31).  In  these  other  studies,  the  functional  and  molecular  analysis  of T  cell 
receptor gene expression in T  cell lines and T  cell clones has indicated that T 
cell clones expressing  the  same clonotypic Ti/3 variable (V) gene  product can 
express  either  T4  or  T8  antigen  and  can  exert  inducer,  suppressor,  and/or 
cytotoxic function. Moreover, this analysis indicated that individual members of 
the V gene family could not be linked to Ti diversity (D) and/or joining (J) and 
constant  (C)  region  segments  and  that  Ti  a  chains  of such  clones  were  also 
distinct.  The implications of these findings for conventional MHC-restricted T 
cells is that the use of a single Ti/3 V gene is not restricted to any functionally or 
phenotypically defined population (31). In contrast, the NKTa clonotype appears 
to be very closely linked in all NK clones to the non-MHC-restricted  cytotoxic 
specificity for the TNKTAR antigen.  Thus,  the NKTa structure may he defined 
by a  more  complex  VDJ  region  on  Ti  /3  and  this  region  may  be  critical  in 
determining the MHC-independent specificity of NK active clones with a mature 
T  cell phenotype. 
Taken together,  we can conclude from our studies that the NKTa clonotype 
defines a  distinct population  of peripheral  blood cells. This raises at least two 
major questions. First, is this clonotypic antigen unique for one individual or can SCHMIDT  ET  AL.  823 
it be  found in  other individuals as well?  Since the  NKTa  + population is very 
small, this question cannot be easily answered by immunofluorescent analyses, 
even  if  immune  rosetting  is  used  to  enrich  for  these  cells.  Thus,  in  vitro 
stimulation and propagation of clonotype positive cells from other individuals 
and  clonal  expansion  will  be  necessary to  evaluate  the  functional use  of this 
antigen in the general population. The second question concerns the functional 
role of the NKTa antigen in the individual we have studied. Since NK active 
NKTa  + clones  with  different phenotypes  have  been  derived  from  the  same 
individual at various times over a  period of 3  yr, it is unlikely that such cells 
would exist primarily to control tumor cell growth, or that they are present in 
response to a specific infectious agent. The finding that NKTa  + cells specifically 
recognize a  target antigen (TNKTAR) that is broadly expressed on early hema- 
topoietic cells and activated cells suggests that NKTa  ÷ effector cells may have an 
immunoregulatory function in vivo. Further studies are in progress to evaluate 
the role of TNKTAR and the involvement of NKTa  + cells in such functions as 
the regulation of hematopoietic differentiation, B cell stimulation and differen- 
tiation, as well as in the regulation of NK cell function itself. 
Summary 
Over a period of 3 yr, a series of ten NK clones that express a unique clonotypic 
T  cell receptor-like structure, termed NKTa, has been generated from a single 
individual. These clones were derived from either peripheral blood nonadherent 
cell fractions (JT9, JT 10, JT 11), NKH2-purified cells (CNK8, CNK9), or NKTa- 
purified cells  (CNKll,  CNK12,  CNK13,  CNK14,  CNK15).  Flow  cytometric 
analysis of peripheral blood mononuclear cells from this individual showed that 
NKTa  + cells occur with a frequency of ~0.15%. The existence of NKTa  + cells 
in peripheral blood was confirmed by use of immunorosette enrichment tech- 
niques, flow cytometric purification, and subsequent clonal expansion of NKTa  + 
cells.  Phenotypic analysis of NKTa  + clones showed that all expressed NKH 1 as 
well as T3, T8, T11, T12, and Mol antigens. Only five of ten clones expressed 
NKH2 antigen. All NKTa  + clones had broad cytolytic activity against a series of 
seven  different target  cells  that  was  similar  to  that  of other  NK  clones.  In 
addition,  cytotoxicity of each  clone  could  be  inhibited  by  preincubation  of 
effector cells with monoclonal anti-NKTa or by preincubation of target cells with 
monoclonal anti-TNK-rAR.  Although half of the NKTa  + clones appeared pheno- 
typically different from the other half with regard to the expression of NKH2 
antigen, analysis of T cell receptor gene rearrangements indicated that all NKTa  + 
clones contained identical gene rearrangements of C32. 
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